狗驅蟲劑市場機會、成長促進因素、產業趨勢分析與預測 2024 - 2032 年

Dog Dewormers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年10月01日 | 出版商:

Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023年，全球狗用驅蟲劑市場價值為14億美元，預計2024年至2032年複合年成長率為9.5%。這一趨勢的主要因素市場成長。寵物擁有量的上升趨勢極大地影響了市場的擴張。生活方式的改變和城市化正在導致越來越多的人透過寵物（尤其是狗）尋求陪伴。報告顯示，相當大比例的美國家庭擁有寵物，反映出更廣泛的全球趨勢，即獸醫護理和寵物產品支出持續成長。

隨著寵物主人優先考慮採取預防措施來維持寵物健康，對有效驅蟲解決方案的需求預計將會成長。狗驅蟲劑市場按產品類型分為外用溶液、片劑和咀嚼片以及注射劑。片劑和咀嚼片細分市場成為最高的收入來源，到2023 年將帶來約7.686 億美元的收入。更容易被狗攝入，並且經常被接受無需大驚小怪。狗驅蟲劑的通路包括獸醫診所、零售藥局、線上平台和寵物商店。

獸醫診所部門產生的收入最多，2023 年總計約為 5.602 億美元。這種專業指導增強了寵物主人對他們選擇的產品的信心，增強了他們對安全性和功效的認知。在北美，狗驅蟲劑市場到 2023 年將產生 5.133 億美元的收入，預計在預測期內複合年成長率為 9.1%。該地區，尤其是美國和加拿大，是全球寵物擁有率最高的地區之一。

市場範圍
開始年份	2023年
預測年份	2024-2032
起始值	14億美元
預測值	31億美元
複合年成長率	9.5%

養寵物家庭數量的增加刺激了對狗驅蟲劑的需求。此外，人們也越來越意識到寵物預防保健的重要性。隨著寵物主人對寄生蟲感染危險的了解越來越多，他們更傾向於投資定期驅蟲治療，以確保他們的狗保持健康且沒有寄生蟲

產業生態系統分析
產業影響力
- 成長動力
  - 增加寵物擁有量
  - 驅蟲劑配方的進步
  - 更重視人畜共通傳染病
  - 人們對寵物健康的認知不斷增強
- 產業陷阱與挑戰
  - 監管挑戰
成長潛力分析
監管環境
技術景觀
未來市場趨勢
差距分析
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品類型，2021 - 2032 年

主要趨勢
片劑和咀嚼片
局部解決方案
注射

第 6 章：市場估計與預測：按配銷通路，2021 - 2032 年

主要趨勢
獸醫診所
零售藥局
線上平台
寵物店

第 7 章：市場估計與預測：按地區分類，2021 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 8 章：公司簡介

Bayer AG
Beaphar
Bimeda, Inc.
Boehringer Ingelheim International GmbH
Ceva Sante Animale
Durvet Animal Health Products
Elanco Animal Health Incorporated
Jurox Pty Limited
Merck & Co., Inc.
Ourofino Animal Health
PetIQ, LLC.
Sava Healthcare Limited
Vetoquinol
Virbac SA
Zoetis Inc.

簡介目錄

Product Code: 11674

The Global Dog Dewormers Market was valued at USD 1.4 billion in 2023 and is projected to expand at a 9.5% CAGR from 2024 to 2032. The surge in pet ownership, coupled with an increasing emphasis on preventing zoonotic diseases, is a major factor driving this market growth. The rising trend of pet ownership significantly influences market expansion. Changing lifestyles and urbanization are leading more individuals to seek companionship through pets, particularly dogs. Reports indicate that a substantial percentage of households in the U.S. own pets, reflecting a broader global trend where spending on veterinary care and pet products continues to rise.

As pet owners prioritize preventive measures to maintain pet health, the demand for effective deworming solutions is expected to grow. The dog dewormers market is categorized by product type into topical solutions, tablets & chewable treats, and injections. The tablets and chewable treats segment emerged as the highest revenue generator, bringing in approximately USD 768.6 million in 2023. This segment's popularity stems from its convenience and high compliance rates among pet owners, as flavored chewables are easier for dogs to ingest and are often accepted without fuss. Distribution channels for dog dewormers include veterinary clinics, retail pharmacies, online platforms, and pet stores.

The veterinary clinics segment generated the most revenue, totaling around USD 560.2 million in 2023. The expertise provided by veterinarians ensures that dewormers are tailored to meet each dog's specific needs. This professional guidance boosts pet owners' confidence in the products they choose, enhancing their perception of safety and efficacy. In North America, the dog dewormers market generated USD 513.3 million in revenue in 2023 and is anticipated to grow at a CAGR of 9.1% over the forecast period. This region, particularly the United States and Canada, boasts one of the highest pet ownership rates globally.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$1.4 Billion
Forecast Value	$3.1 Billion
CAGR	9.5%

The increasing number of pet-owning households fuels the demand for dog dewormers. Furthermore, there is a growing awareness of the significance of preventive healthcare for pets. As pet owners become more educated about the dangers of parasitic infections, they are more inclined to invest in regular deworming treatments to ensure their dogs remain healthy and parasite-free

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increased pet ownership
  - 3.2.1.2 Advancements in dewormer formulations
  - 3.2.1.3 Increased focus on zoonotic diseases
  - 3.2.1.4 Growing awareness about pet health
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Regulatory challenges
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Future market trends
3.7 Gap analysis
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Tablets and chewable treats
5.3 Topical solutions
5.4 Injections

Chapter 6 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Veterinary clinics
6.3 Retail pharmacies
6.4 Online platforms
6.5 Pet stores

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Italy
- 7.3.5 Spain
- 7.3.6 Netherlands
- 7.3.7 Rest of the Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 Saudi Arabia
- 7.6.2 South Africa
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa